Arginine-vasopressin modulates intracellular pH via v1 and v2 receptors in renal collecting duct cells

被引:5
|
作者
Rivarola, Valeria [1 ]
Ford, Paula [1 ]
Flamenco, Maria del Pilar [1 ]
Galizia, Luciano [1 ]
Capurro, Claudia [1 ]
机构
[1] Univ Buenos Aires, Fac Med, Dept Fisiol & Biofis, Lab Biomembranas, RA-1121 Buenos Aires, DF, Argentina
关键词
Na+/H+ and Cl-/HCO3- exchangers; CFTR; RCCD1 cell line;
D O I
10.1159/000107538
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Arginine- vasopressin ( AVP) has been proposed to be involved in the modulation of acid-base transporters; however, the nature of the mechanisms underlying AVP direct action on intracellular pH ( pH(i)) in the cortical collecting duct ( CCD) is not yet clearly defined. The aim of the present study was to elucidate which are the proteins implicated in AVP modulation of pHi, as well as the receptors involved in these responses using a CCD cell line (RCCD (1)); pH (i) was monitored with the fluorescent dye BCECF in basal conditions and after stimulation with basolateral 10(-8) M AVP. Specific V1- or V2- receptor antagonists were also used. RT- PCR studies demonstrated that RCCD (1) cells express V1a and V2 receptors. Functional studies showed that while V2- receptor activation induced a biphasic response ( alkalinization-acidification), V1- receptor activation resulted in an intracellular acidification. The V2- mediated alkalinization phase involves the activation of basolateral NHE- 1 isoform of the Na+/ H+ exchanger while in the acidification phase CFTR is probably implicated. On the other hand, V1- mediated acidification was due to activation of a Cl-/ HCO 3 exchanger. We conclude that in RCCD (1) cells AVP selectively activates, via a complex of V1 and V2 receptor- mediated actions, different ion transporters linked to pH (i) regulation which might have physiological implications.
引用
收藏
页码:549 / 558
页数:10
相关论文
共 50 条
  • [21] Vasopressin Increases Urinary Acidification via V1a Receptors in Collecting Duct Intercalated Cells
    Giesecke, Torsten
    Himmerkus, Nina
    Leipziger, Jens
    Bleich, Markus
    Koshimizu, Taka-Aki
    Faehling, Michael
    Smorodchenko, Alina
    Shpak, Julia
    Knappe, Carolin
    Isermann, Julian
    Ayasse, Niklas
    Kawahara, Katsumasa
    Schmoranzer, Jan
    Gimber, Niclas
    Paliege, Alexander
    Bachmann, Sebastian
    Mutig, Kerim
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (06): : 946 - 961
  • [22] VASOPRESSIN V1/V2 RECEPTOR INTERACTIONS AND OVINE FETAL RENAL AND CARDIOVASCULAR FUNCTION
    ERVIN, MG
    TERRY, KA
    CALVARIO, GC
    ROSS, MG
    LEAKE, RD
    FISHER, DA
    CLINICAL RESEARCH, 1992, 40 (01): : A75 - A75
  • [23] Vasopressin/V2 receptor stimulates renin synthesis in the collecting duct
    Gonzalez, Alexis A.
    Cifuentes-Araneda, Flavia
    Ibaceta-Gonzalez, Cristobal
    Gonzalez-Vergara, Alex
    Zamora, Leonardo
    Henriquez, Ricardo
    Rosales, Carla B.
    Navar, L. Gabriel
    Prieto, Minolfa C.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (04) : F284 - F293
  • [24] INDUCTION OF V2 RECEPTORS IN RENAL MEDULLA OF HOMOZYGOUS BRATTLEBORO RATS BY ARGININE VASOPRESSIN
    CORNETT, LE
    BRECKINRIDGE, SM
    KOIKE, TI
    PEPTIDES, 1989, 10 (05) : 985 - 991
  • [25] Phosphoproteomic identification of vasopressin V2 receptor-dependent signaling in the renal collecting duct
    Deshpande, Venkatesh
    Kao, Anika
    Raghuram, Viswanathan
    Datta, Arnab
    Chou, Chung-Lin
    Knepper, Mark A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 317 (04) : F789 - F804
  • [26] Cerebral vasoconstriction produced by vasopressin in conscious goats:: role of vasopressin V1 and V2 receptors and nitric oxide
    Fernández, N
    Martinez, MA
    García-Villalón, AL
    Monge, L
    Diéguez, G
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (08) : 1837 - 1844
  • [27] Alterations of renal vasopressin V1A and V2 receptors in spontaneously hypertensive rats
    Tahara, A
    Tsukada, J
    Tomura, Y
    Wada, K
    Kusayama, T
    Ishii, N
    Yatsu, T
    Uchida, W
    Taniguchi, N
    Tanaka, A
    PHARMACOLOGY, 2003, 67 (02) : 106 - 112
  • [28] Coronary vasoconstriction produced by vasopressin in anesthetized goats.: Role of vasopressin V1 and V2 receptors and nitric oxide
    Fernández, N
    García, JL
    García-Villalón, AL
    Monge, L
    Gómez, B
    Diéguez, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 342 (2-3) : 225 - 233
  • [29] INTERNALIZATION OF VASOPRESSIN ANALOGS IN KIDNEY AND SMOOTH-MUSCLE CELLS - EVIDENCE FOR RECEPTOR-MEDIATED ENDOCYTOSIS IN CELLS WITH V2 OR V1 RECEPTORS
    LUTZ, W
    SANDERS, M
    SALISBURY, J
    KUMAR, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6507 - 6511
  • [30] VASOACTIVE EFFECTS OF ARGININE-VASOPRESSIN IN HEALTHY-SUBJECTS AND PATIENTS WITH A V2 RECEPTOR DEFECT
    VANLIEBURG, AF
    KNOERS, VVAM
    MONNENS, LAH
    THIEN, T
    SMITS, P
    KIDNEY INTERNATIONAL, 1995, 48 (04) : 1364 - 1364